Studies indicate that pregnant women with COVID-19, particularly in their third trimester, experience a dysregulation of innate immunity, characterized by lower levels of IFNγ and reduced expression of CD14 and HLA-DR on monocytes. The gene discussed is CD14; the disease is COVID-19.